Cost-Effectiveness and Cost-Utility Analysis of Belimumab for the Treatment of Patients with Systemic Lupus Erythematosus in Portugal
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.354
https://www.valueinhealthjournal.com/article/S1098-3015(13)02259-6/fulltext
Title :
Cost-Effectiveness and Cost-Utility Analysis of Belimumab for the Treatment of Patients with Systemic Lupus Erythematosus in Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02259-6&doi=10.1016/j.jval.2013.08.354
First page :
A384
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
340